The United States Food and Drug Administration (FDA) has granted a Fast Track Designation to imaging agent 99 mTc-maraciclatide for use in endometriosis diagnosis. A non-invasive test for endometriosis with reliable and consistent performance could transform women’s healthcare. This technology, developed by Serac healthcare, will not only allow fast assessment of the condition, it will also … Continue reading Endometriosis Update: FDA Fast Tracks Diagnostic Imaging for Superficial Endometriosis